Eye drop for treatment of nearsightedness and preparation method of eye drop

A technology of eye drops and myopia, which is applied in the field of medicine, can solve the problems of easy recurrence, temporary cure, side effects, etc., and achieve the effect of overcoming side effects and remarkable effect

Inactive Publication Date: 2019-06-21
陈锦济生物医学技术(广州)有限公司
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment methods for myopia include drug therapy, surgical therapy and other treatments; there are many kinds of drug therapy, including atropine, neostigmine, tropicamide, etc., but they have certain side effects and are prone to recurrence
Surgical treatment is risky and has sequelae; other treatments such as wearing optical glasses can only solve the daily vision problems of visually impaired patients, not the root cause

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The eye drops for the treatment of myopia of the present invention comprises the following raw materials in parts by weight: silkworm 5, dendrobium powder 5, privet fruit 70, cassia seed 90, vitamin B 1 50, vitamin C50, borneol 5, mouse nerve growth factor 5, vitamin B 12 50, sodium chloride 5, piracetam 60.

[0026] The present invention is used for the preparation method of the eyedrop of treating myopia, and the steps are as follows:

[0027] 1) Put Ligustrum lucidum and Cassia seed into a casserole with water, fry with low heat for 4-6 hours, let cool, filter and collect the filtrate for later use;

[0028] 2) Add the filtrate in step 1 to silkworm, dendrobium powder, vitamin B 1 , Vitamin B 12 , vitamin C, then add borneol and sodium chloride, stir evenly, adjust the pH to 6-7, then sterilize, subpackage and cool.

[0029] 3) Add mouse nerve growth factor and piracetam powder to the cooling liquid in step 2, stir it into the cooling liquid, and then obtain the ...

Embodiment 2

[0031] The eye drops for treating myopia of the present invention comprises the following raw materials in parts by weight: 10 white silkworms, 10 dendrobium powder, 80 privet seeds, 100 cassia seeds, vitamin B 1 70, vitamin C60, borneol 10, mouse nerve growth factor 10, vitamin B 12 50, sodium chloride 10, piracetam 70.

[0032] The present invention is used for the preparation method of the eyedrop of treating myopia, and the steps are as follows:

[0033] 1) Put Ligustrum lucidum and Cassia seed into a casserole with water, fry with low heat for 4-6 hours, let cool, filter and collect the filtrate for later use;

[0034] 2) Add the filtrate in step 1 to silkworm, dendrobium powder, vitamin B 1 , Vitamin B 12 , vitamin C, then add borneol and sodium chloride, stir evenly, adjust the pH to 6-7, then sterilize, subpackage and cool.

[0035] 3) Add mouse nerve growth factor and piracetam powder to the cooling liquid in step 2, stir it into the cooling liquid, and then obtai...

Embodiment 3

[0037] The eye drops for the treatment of myopia of the present invention comprises the following raw materials in parts by weight: silkworm 15, dendrobium powder 15, privet privet 90, cassia 100, vitamin B 1 80, vitamin C70, borneol 15, mouse nerve growth factor 15, vitamin B 12 80, sodium chloride 15, piracetam 80.

[0038] The present invention is used for the preparation method of the eyedrop of treating myopia, and the steps are as follows:

[0039] 1) Put Ligustrum lucidum and Cassia seed into a casserole with water, fry with low heat for 4-6 hours, let cool, filter and collect the filtrate for later use;

[0040] 2) Add the filtrate in step 1 to silkworm, dendrobium powder, vitamin B 1 , Vitamin B 12 , vitamin C, then add borneol and sodium chloride, stir evenly, adjust the pH to 6-7, then sterilize, subpackage and cool.

[0041] 3) Add mouse nerve growth factor and piracetam powder to the cooling liquid in step 2, stir it into the cooling liquid, and then obtain th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medication and particularly relates to an eye drop for treatment of nearsightedness and a preparation method of the eye drop. The eye drop comprises, by weight, 5-15 parts of silkworm larva, 5-15 parts of caulis dendrobii powder, 70-79 parts of fructus ligustri lucidi, 90-100 parts of semen cassiae, 50-80 parts of Vitamin B1, 50-70 parts of Vitamin C, 5-15 parts of borneol, 5-15 parts of mouse nerve growth factors, 50-80 parts of Vitamin B12, 5-15 parts of sodium chloride and 60-80 parts of piracetam. By the arrangement, problems that drug therapy is proneto side effects, defects prone to recurrence, risks and sequelae of surgical treatment and wearing optical glasses can only overcome the shortcoming of daily vision of patients with visual impairmentbut not the root cause are solved, and the eye drop adopts natural raw materials is developed into a safe, efficient and high-quality product with reasonable compatibility and synergistic effect, remarkable effect in the treatment of nearsightedness and safety and efficiency.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to an eye drop for treating myopia and a preparation method thereof. Background technique [0002] According to the research report of the World Health Organization, the number of myopia patients in China is as many as 700 million, and the myopia rate of high school students and college students has exceeded 80%, and it is increasing year by year. . According to a conservative estimate, by 2020, the myopia population in my country will be close to 804 to 1.01 billion. Current myopia treatment methods include drug therapy, surgical therapy and other treatments; drug therapy is of a great variety, including atropine, neostigmine, tropicamide, etc., but has certain side effects and is prone to recurrence. Surgical treatment is risky and has sequelae; other treatments such as wearing optical glasses can only solve the daily vision problems of patients with visual impairment, not th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/18A61P27/10A61K31/045A61K31/375A61K31/4015A61K31/714A61K33/14A61K35/64A61K36/482A61K36/638A61K36/8984
Inventor 陈帝江
Owner 陈锦济生物医学技术(广州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap